NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02993523,A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy,https://clinicaltrials.gov/study/NCT02993523,Viale-a,ACTIVE_NOT_RECRUITING,"Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible for fighting infections). Successful treatment of AML is dependent on what subtype of AML the participant has, and the age of the participant when diagnosed.

Venetoclax is an experimental drug that kills cancer cells by blocking a protein (part of a cell) that allows cancer cells to stay alive. This study is designed to see if adding venetoclax to azacitidine works better than azacitidine on its own.

This is a Phase 3, randomized, double-blind (treatment is unknown to participants and doctors), placebo controlled study in patients with AML who are \>= 18 or more years old and have not been treated before. Participants who take part in this study should not be suitable for standard induction therapy (usual starting treatment). AbbVie is funding this study which will take place at approximately 180 hospitals globally and enroll approximately 400 participants.

In this study, 2/3 of participants will receive venetoclax every day with azacitidine and the remaining 1/3 will receive placebo (dummy) tablets with azacitidine.

Participants will continue to have study visits and receive treatment for as long as they are having a clinical benefit. The effect of the treatment on AML will be checked by taking blood, bone marrow, scans, measuring side effects and by completing health questionnaires. Blood and bone marrow tests will be completed to see why some people respond better than others. Additional blood tests will be completed for genetic factors and to see how long the drug remains in the body.",YES,Acute Myeloid Leukemia (AML),DRUG: Azacitidine|DRUG: Venetoclax|DRUG: Placebo,"Overall Survival (OS), OS is defined as the number of days from the date of randomization to the date of death. Log rank test was used to compare the OS distribution between two treatment arms. Cox regression was used to report the hazard ratio., From the study start up to death or alive or lost to follow-up (up to approximately 4.8 years; data cut off date: 1 December 2021)|Percentage of Participants With Complete Remission (CR) and Complete Remission With Incomplete Marrow Recovery (CRi), CR and CRi was calculated based on current International Working Group (IWG) criteria. CR is defined as absolute neutrophil count \>10\^3/ microliter (mcL), platelets \>10\^5/mcL, red cell transfusion independence, and bone marrow with \<5% blasts. CRi is defined as bone marrow with less than 5% blasts, and absolute neutrophils of ≤10\^3/mcL or platelets ≤10\^5/mcL. Percentages are rounded off to whole number at the nearest decimal., From the study start up to death (up to approximately 4.8 years; data cut-off date: 1 December 2021)","Event-free Survival (EFS), EFS will be defined as the number of days from randomization to the date of progressive disease, relapse from CR or CRi, treatment failure or death from any cause., Measured up to 2 years after the last participant is randomized|Global Health Status/Quality of Life (GHS/QoL), Improvement in GHS/QoL will be assessed using the Patient Reported Outcomes Measurement Information System (PROMIS) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30)., Measured at participant's Day 1 of Cycle 1 (each cycle is 28 days) and at Day 1 of every Cycle thereafter for up to 2 years following the last subject last visit|Percentage of Participants Achieving Composite Complete Remission (CR or CRi), This will be calculated based on current International Working Group (IWG) criteria. CR is defined as absolute neutrophil count \> 10\^3/mcL, platelets \> 10\^5/mcL, red cell transfusion independence, and bone marrow with \< 5% blasts. CRi is defined as bone marrow with less than 5% blasts, and absolute neutrophils of \<= 10\^3/mcL or platelets \<= 10\^5/mcL., Up to 6 months after the first 225 participants are randomized|Complete Remission or Complete Remission With Partial Hematologic Recovery Rate (CR+CRh), A response of CRh is defined as Bone marrow with \<5% blasts, peripheral blood neutrophil count \>0.5\*10\^3/mcL and peripheral blood platelet count \>0.5\*10\^5/mcL., Measured up to 2 years after the last participant is randomized|Post Baseline Transfusion Independence Rate, Transfusion Independence is defined as a period of 56 days with no transfusion between first dose of study drug and the last dose of study drug + 30 days. The rate of conversion for red blood cells (RBC) and platelets is defined as percentage of participants being post-baseline transfusion independent from baseline transfusion dependence., Measured up to 2 years after the last participant is randomized|Complete Remission (CR) Rate, The percentage of participants with complete remission (CR) will be calculated based on the modified IWG criteria for AML., Measured up to 2 years after the last participant is randomized|Fatigue/Quality of Life (QoL), Fatigue QoL will be assessed using the Patient Reported Outcomes Measurement Information System (PROMIS) Cancer Fatigue Short Form (SF) 7a global fatigue score, Measured at participant's Day 1 of Cycle 1 (each cycle is 28 days) and at Day 1 of every Cycle thereafter for up to 2 years following the last participant last visit",,AbbVie,"Genentech, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE3,443,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",M15-656|2016-001466-28,2017-02-02,2021-12-01,2026-01-23,2016-12-15,2023-01-27,2024-06-27,"City of Hope /ID# 154105, Duarte, California, 91010, United States|University of California, Los Angeles /ID# 154107, Los Angeles, California, 90095, United States|University of California, Davis Comprehensive Cancer Center /ID# 162725, Sacramento, California, 95817, United States|Emory Midtown Infectious Disease Clinic /ID# 162534, Atlanta, Georgia, 30322, United States|Northwestern University Feinberg School of Medicine /ID# 201133, Chicago, Illinois, 60611-2927, United States|University of Chicago Medicine /ID# 154108, Chicago, Illinois, 60637-1426, United States|Fort Wayne Medical Oncology /ID# 157190, Fort Wayne, Indiana, 46804, United States|Cotton-O'Neil Clinical Res Ctr /ID# 155136, Topeka, Kansas, 66606, United States|Norton Cancer Institute /ID# 154992, Louisville, Kentucky, 40202-3700, United States|EMMC Cancer Care /ID# 154991, Brewer, Maine, 04412, United States|Johns Hopkins University /ID# 154104, Baltimore, Maryland, 21287, United States|Massachusetts General Hospital /ID# 200752, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center /ID# 201155, Boston, Massachusetts, 02215-5400, United States|Dana-Farber Cancer Institute /ID# 167009, Boston, Massachusetts, 02215, United States|Sepctrum Health Medical Center /ID# 159522, Grand Rapids, Michigan, 49503, United States|Columbia Univ Medical Center /ID# 154101, New York, New York, 10032-3725, United States|Memorial Sloan Kettering Cancer Center-Koch Center /ID# 165077, New York, New York, 10065-6007, United States|Duke Cancer Center /ID# 154106, Durham, North Carolina, 27710-3000, United States|University of Pittsburgh MC /ID# 154102, Pittsburgh, Pennsylvania, 15260, United States|Tennessee Oncology-Nashville Centennial /ID# 200854, Nashville, Tennessee, 37203-1632, United States|University of Texas MD Anderson Cancer Center /ID# 154100, Houston, Texas, 77030, United States|Baylor Scott & White Medical Center- Temple /ID# 157191, Temple, Texas, 76508-0001, United States|University of Utah /ID# 157192, Salt Lake City, Utah, 84112-5500, United States|University Of Vermont Medical /ID# 157196, Burlington, Vermont, 05405, United States|Princess Alexandra Hospital /ID# 154272, Woolloongabba, Queensland, 4102, Australia|Royal Adelaide Hospital /ID# 154271, Adelaide, South Australia, 5000, Australia|Alfred Health /ID# 154275, Melbourne, Victoria, 3004, Australia|St Vincent's Hospital Melbourne /ID# 155094, Melbourne, Victoria, 3065, Australia|The Royal Melbourne Hospital /ID# 155095, Parkville, Victoria, 3050, Australia|Sir Charles Gairdner Hospital /ID# 163924, Nedlands, Western Australia, 6009, Australia|Royal Perth Hospital /ID# 154274, Perth, Western Australia, 6000, Australia|Universitaetsklinikum St. Poelten /ID# 167436, Sankt Poelten, Niederoesterreich, 3100, Austria|Ordensklinikum Linz GmbH Barmherzige Schwestern /ID# 154888, Linz, Oberoesterreich, 4010, Austria|Ordensklinikum Linz GmbH Elisabethinen /ID# 154885, Linz, Oberoesterreich, 4010, Austria|Medizinische Universitaet Graz /ID# 157882, Graz, Steiermark, 8036, Austria|Duplicate_Landeskrankenhaus Salzburg /ID# 169719, Salzburg, 5020, Austria|Hanusch Krankenhaus /ID# 155676, Wien, 1140, Austria|UZ Brussel /ID# 153393, Jette, Bruxelles-Capitale, 1090, Belgium|UCL Saint-Luc /ID# 153391, Woluwe-Saint-Lambert, Bruxelles-Capitale, 1200, Belgium|UZ Gent /ID# 153392, Gent, Oost-Vlaanderen, 9000, Belgium|AZ Sint-Jan Brugge /ID# 154041, Brugge, 8000, Belgium|Hospital de Clinicas de Porto Alegre /ID# 157779, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 153099, Ribeirão Preto, Sao Paulo, 14051-140, Brazil|Instituto de Ensino e Pesquisa São Lucas /ID# 157778, São Paulo, Sao Paulo, 01236-030, Brazil|Instituto do Câncer do Estado de São Paulo - ICESP /ID# 153095, São Paulo, Sao Paulo, 01246-000, Brazil|Tom Baker Cancer Centre /ID# 159645, Calgary, Alberta, T2N 4N2, Canada|St. Paul's Hospital /ID# 159644, Vancouver, British Columbia, V6Z 1Y6, Canada|Juravinski Cancer Centre /ID# 153650, Hamilton, Ontario, L8V 1C3, Canada|Ottawa Hospital Research Institute /ID# 153541, Ottawa, Ontario, K1H 8L6, Canada|Princess Margaret Cancer Centre /ID# 153651, Toronto, Ontario, M5G 2M9, Canada|Fujian Medical University Union Hospital /ID# 167314, Fuzhou, Fujian, 350001, China|Nanfang Hospital of Southern Medical University /ID# 170148, Guangzhou, Guangdong, 510515, China|The Second Hospital of Hebei Medical University /ID# 167316, Shijiazhuang, Hebei, 050000, China|Henan Cancer Hospital /ID# 167320, Zhengzhou, Henan, 450008, China|Tongji Hospital Tongji Medical College Huazhong University of Science and Techno /ID# 167315, Wuhan, Hubei, 430022, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 167493, Wuhan, Hubei, 430022, China|Jiangsu Province Hospital /ID# 167489, Nanjing, Jiangsu, 210029, China|The First Hospital of Jilin University /ID# 167490, Changchun, Jilin, 130021, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 167318, Shanghai, Shanghai, 200065, China|West China Hospital, Sichuan University /ID# 167492, Chengdu, Sichuan, 610041, China|Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 167487, Tianjin, Tianjin, 300020, China|The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 167317, Hangzhou, Zhejiang, 310006, China|Qilu Hospital of Shandong University /ID# 167485, Jinan, 250012, China|Clinical Hospital Dubrava /ID# 153515, Zagreb, Grad Zagreb, 10000, Croatia|Klinicki bolnicki centar Zagreb /ID# 153383, Zagreb, Grad Zagreb, 10000, Croatia|Duplicate_Klinicki bolnicki centar Osijek /ID# 153623, Osijek, Osjecko-baranjska Zupanija, 31000, Croatia|Fakultni Nemocnice Brno /ID# 154019, Brno, 625 00, Czechia|Fakultni nemocnice Hradec Kralove /ID# 154021, Hradec Kralove, 500 05, Czechia|Fakultni nemocnice Ostrava /ID# 154017, Ostrava, 708 52, Czechia|Fakultni nemocnice Plzen /ID# 154018, Plzen, 305 99, Czechia|Aalborg University Hospital /ID# 154047, Aalborg, Nordjylland, 9000, Denmark|Tampere University Hospital /ID# 154963, Tampere, Pirkanmaa, 33520, Finland|Helsinki University Hospital /ID# 155223, Helsinki, Uusimaa, 00290, Finland|Turku University Hospital /ID# 154964, Turku, 20520, Finland|CHU Bordeaux - Hopital Haut Leveque /ID# 153789, Pessac, Gironde, 33604, France|Chu Angers /Id# 153792, Angers, 49933, France|AP-HP - Hopital Saint-Louis /ID# 153787, Paris, 75010, France|IUCT Oncopole /ID# 153788, Toulouse Cedex 9, 31059, France|Universitaetsklinikum Ulm /ID# 153054, Ulm, Baden-Wuerttemberg, 89081, Germany|Universitaetsklinikum Frankfurt /ID# 153060, Frankfurt am Main, Hessen, 60590, Germany|Universitaetsklinikum Muenster /ID# 153059, Muenster, Nordrhein-Westfalen, 48149, Germany|Universitaetsklinikum Halle (Saale) /ID# 153058, Halle (Saale), 06120, Germany|Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 153056, Hamburg, 20246, Germany|Medizinische Hochschule Hannover /ID# 153055, Hannover, 30625, Germany|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 153812, Szeged, Csongrad, 6725, Hungary|Debreceni Egyetem Klinikai Kozpont /ID# 153814, Debrecen, Hajdu-Bihar, 4032, Hungary|Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz Josa Andras Okta /ID# 169854, Nyíregyháza, Nyiregyhaza, 4400, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz /ID# 153813, Kaposvár, Somogy, 7400, Hungary|Semmelweis Egyetem /ID# 153816, Budapest, 1085, Hungary|Duplicate_Semmelweis Egyetem /ID# 153815, Budapest, 1088, Hungary|Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 158990, Budapest, 1097, Hungary|The Chaim Sheba Medical Center /ID# 154173, Ramat Gan, Tel-Aviv, 5265601, Israel|Tel Aviv Sourasky Medical Center /ID# 154175, Tel Aviv-Yafo, Tel-Aviv, 6423906, Israel|Assaf Harofeh Medical Center /ID# 158063, Be'er Ya'aqov, 70300, Israel|Rambam Health Care Campus /ID# 154174, Haifa, 3109601, Israel|Hadassah /ID# 154172, Jerusalem, 91120, Israel|Rabin Medical Center /ID# 154176, Petach Tikva, 4941492, Israel|Presidio Ospedaliero Vito Fazzi /ID# 170837, Lecce, Puglia, 73100, Italy|Fondazione PTV Policlinico Tor Vergata /ID# 152881, Rome, Roma, 00133, Italy|Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 171220, Ancona, 60126, Italy|Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni /ID# 152875, Bergamo, 24127, Italy|IRCCS Azienda Ospedaliero-Universitaria di Bologna /ID# 152883, Bologna, 40138, Italy|Ospedale Policlinico San Martino /ID# 158104, Genova, 16132, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 152882, Milan, 20122, Italy|Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli /ID# 152879, Napoli, 80131, Italy|Grande Ospedale Metropolitano Bianchi Melacrino Morelli /ID# 152877, Reggio Calabria, 89124, Italy|Azienda Ospedaliero-Universitaria Sant'Andrea /ID# 152876, Rome, 00189, Italy|Aichi Cancer Center Hospital /ID# 200824, Nagoya-shi, Aichi, 464-8681, Japan|University of Fukui Hospital /ID# 167432, Yoshida-gun, Fukui, 910-1193, Japan|National Hospital Organization Kyushu Cancer Center /ID# 201111, Fukuoka-shi, Fukuoka, 811-1395, Japan|Kyushu University Hospital /ID# 169095, Fukuoka-shi, Fukuoka, 812-8582, Japan|Gunmaken Saiseikai Maebashi Hospital /ID# 168316, Maebashi-shi, Gunma, 371-0821, Japan|National Hospital Organization Mito Medical Center /ID# 168219, Higashi, Ibaraki, 311-3193, Japan|Hitachi General Hospital /ID# 201109, Hitachi-shi, Ibaraki, 317-0077, Japan|Duplicate_Kyoto Prefectural University of Medicine /ID# 167661, Kyoto-shi, Kyoto, 602-8566, Japan|Tohoku University Hospital /ID# 169259, Sendai-shi, Miyagi, 9808574, Japan|Nagasaki University Hospital /ID# 168632, Nagasaki-shi, Nagasaki, 852-8501, Japan|Okayama University Hospital /ID# 204124, Okayama-shi, Okayama, 700-8558, Japan|Duplicate_Kindai University Hospital /ID# 167662, Osaka-sayama-shi, Osaka, 589-8511, Japan|Osaka Metropolitan University Hospital /ID# 169055, Osaka-shi, Osaka, 545-8586, Japan|Saitama Medical University International Medical Center /ID# 167814, Hidaka-shi, Saitama, 350-1298, Japan|Juntendo University Hospital /ID# 168309, Bunkyo-ku, Tokyo, 113-8431, Japan|Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital /ID# 168639, Bunkyo-ku, Tokyo, 113-8677, Japan|The Jikei University Daisan Hospital /ID# 168745, Komae-shi, Tokyo, 201-8601, Japan|NTT Medical Center Tokyo /ID# 167975, Shinagawa-ku, Tokyo, 141-8625, Japan|Yamagata University Hospital /ID# 167634, Yamagata-shi, Yamagata, 990-9585, Japan|Duplicate_Konkuk University Medical Ctr /ID# 153973, Seoul, Seoul Teugbyeolsi, 05030, Korea, Republic of|Seoul National University Hospital /ID# 153675, Seoul, 03080, Korea, Republic of|Samsung Medical Center /ID# 153674, Seoul, 06351, Korea, Republic of|Akershus universitetssykehus /ID# 154279, Nordlenangen, Akershus, 1474, Norway|Drammen Sykehus /ID# 154280, Drammen, Buskerud, 3004, Norway|Haukeland University Hospital /ID# 154281, Bergen, Hordaland, 5021, Norway|Sykehuset Ostfold Kalnes /ID# 157755, Gralum, 1714, Norway|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu /ID# 153389, Wroclaw, Dolnoslaskie, 50-556, Poland|Osrodek Badan Klinicznych przy Szpitalu Specjalistycznym im. Ludwika Rydygiera w /ID# 169846, Krakow, Malopolskie, 31-826, Poland|SP ZOZ Zespol Szpitali Miejskich w Chorzowie /ID# 153385, Chorzow, Slaskie, 41-500, Poland|Duplicate_Hospital de Braga /ID# 154797, Braga, 4710-423, Portugal|IPO Porto FG, EPE /ID# 154138, Porto, 4200-072, Portugal|VA Caribbean Healthcare System /ID# 160507, San Juan, 00921-3201, Puerto Rico|Kuzbass Regional Clinical Hospital /ID# 157461, Kemerovo, Kemerovskaya Oblast, 650099, Russian Federation|Moscow State budget healthcare /ID# 155738, Moscow, Moskva, 125284, Russian Federation|Nizhny Novgorod Regional Clinical Hospital named N.A. Semashko /ID# 153268, Nizhniy Novgorod, Nizhegorodskaya Oblast, 603126, Russian Federation|Duplicate_Regional Oncology Dispensary /ID# 153264, Penza, Penzenskaya Oblast, 440071, Russian Federation|State Institution of Health of the Ryazan Regional Clinical Hospital /ID# 157460, Ryazan, Ryazanskaya Oblast, 390039, Russian Federation|Saratov State Medical University n.a. V.I. Razumovskiy /ID# 153267, Saratov, Saratovskaya Oblast, 410012, Russian Federation|Federal State Budgetary Ins NRC for Hematology of MoH of Russian Federation /ID# 155740, Moscow, 125167, Russian Federation|Samara State Medical University /ID# 157462, Samara, 443099, Russian Federation|University of Pretoria /ID# 153682, Pretoria, Gauteng, 0001, South Africa|Albert Alberts Stem Cell Transplant Centre /ID# 153684, Pretoria, Gauteng, 0044, South Africa|Hospital Universitario de Navarra /ID# 153254, Pamplona, Navarra, 31008, Spain|Hospital Clinic de Barcelona /ID# 153255, Barcelona, 08036, Spain|Hospital Santa Creu i Sant Pau /ID# 153193, Barcelona, 08041, Spain|Hospital Universitario de la Princesa /ID# 153256, Madrid, 28006, Spain|Hospital General Universitario Gregorio Maranon /ID# 153260, Madrid, 28007, Spain|Hospital Universitario 12 de Octubre /ID# 153258, Madrid, 28041, Spain|Hospital Universitario Virgen de la Victoria /ID# 153257, Malaga, 29010, Spain|Hospital Universitario y Politecnico La Fe /ID# 153259, Valencia, 46026, Spain|Akademiska Sjukhuset /ID# 153034, Uppsala, Uppsala Lan, 751 85, Sweden|Uddevalla sjukhus /ID# 156875, Uddevalla, Vastra Gotalands Lan, 451 80, Sweden|Dup_VO Hematologi /ID# 153174, Lund, 221 85, Sweden|Karolinska University Hospital /ID# 170003, Stockholm, 171 76, Sweden|Changhua Christian Hospital /ID# 153899, Changhua city, Changhua County, 50006, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 153902, Kaohsiung, 807, Taiwan|China Medical University Hospital /ID# 153904, Taichung City, 40447, Taiwan|National Taiwan University Hospital /ID# 153900, Taipei City, 100, Taiwan|Hacettepe University Faculty of Medicine /ID# 202073, Ankara, 06100, Turkey|Ankara Universitesi Fakultesi /ID# 155200, Ankara, 06620, Turkey|Ondokuz Mayis Universitesi Tip /ID# 155201, Samsun, 55139, Turkey|Kyiv city clinical hospital #9 /ID# 153510, Kiev, Vinnytska Oblast, 04112, Ukraine|Municipal Non-Profit Enterprise City Clinical Hospital 4 of Dnipro City Council /ID# 153511, Dnipro, 49102, Ukraine|Kyiv Regional Onco Dispensary /ID# 153514, Kyiv, 04107, Ukraine|Poltava Reg Clin Hosp Sklifoso /ID# 153513, Poltava, 36011, Ukraine","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/23/NCT02993523/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/23/NCT02993523/SAP_001.pdf"
